FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masahide Yamazaki

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Physiology

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Masaki Shimizu; Masahide Yamazaki; Toru Horisawa; Akiko Seno; Kazuhide Ohta; Kengo Furuichi; Akihiro Yachie
Catastrophic anti-phospholipid syndrome associated with Escherichia coli O157 infection.
Eriko Morishita; Akiko Sekiya; Tomoe Hayashi; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Hidesaku Asakura; Shinji Nakao; Shigeki Ohtake
Increased macrophage colony-stimulating factor levels in patients with Graves' disease.
Mika Omote; Hidesaku Asakura; Sayuri Takamichi; Masami Shibayama; Tomotaka Yoshida; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Eriko Morishita; Shinji Nakao; Takashi Wada
Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masahide Yamazaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Masaki Shimizu; Masahide Yamazaki; Toru Horisawa; Akiko Seno; Kazuhide Ohta; Kengo Furuichi; Akihiro Yachie
Catastrophic anti-phospholipid syndrome associated with Escherichia coli O157 infection.
Rheumatology (Oxford, England) 2009;48(9):1168-9.
2008: Eriko Morishita; Akiko Sekiya; Tomoe Hayashi; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Hidesaku Asakura; Shinji Nakao; Shigeki Ohtake
Increased macrophage colony-stimulating factor levels in patients with Graves' disease.
International journal of hematology 2008;88(3):272-7.
2008: Mika Omote; Hidesaku Asakura; Sayuri Takamichi; Masami Shibayama; Tomotaka Yoshida; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Eriko Morishita; Shinji Nakao; Takashi Wada
Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Thrombosis research 2008;123(2):390-5.
2008: Tomoe Hayashi; Eriko Morishita; Hiroshi Ohtake; Yoshio Oda; Kazuhide Ohta; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Yasuo Ontachi; Masahide Yamazaki; Hidesaku Asakura; Akiyoshi Takami; Shinji Nakao
Expression of annexin II in human atherosclerotic abdominal aortic aneurysms.
Thrombosis research 2008;123(2):274-80.
2007: Takeshi Echigo; Minoru Hasegawa; Makoto Inaoki; Masahide Yamazaki; Shinichi Sato; Kazuhiko Takehara
Antiphospholipid antibodies in patients with autoimmune blistering disease.
Journal of the American Academy of Dermatology 2007;57(3):397-400.
2007: Masahide Yamazaki; Hisashi Funada
[Immunoglobulin concentrate and G-CSF].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 2 Pt. 1():321-5.
2006: Yasuo Ontachi; Hidesaku Asakura; Yoko Takahashi; Tomoe Hayashi; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Mika Omote; Tomotaka Yoshida; Masahide Yamazaki; Eriko Morishita; Ken-ichi Miyamoto; Shinji Nakao
No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Critical care medicine 2006;34(10):2646-50.
2006: Mika Omote; Tomotaka Yoshida; Hidesaku Asakura; Yasuo Ontachi; Tomoe Hayashi; Eriko Morishita; Masahide Yamazaki; Shinichi Fujita; Sinji Nakao
[The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
Rinsho byori. The Japanese journal of clinical pathology 2006;54(9):903-9.
2006: Hidesaku Asakura; Yoko Takahashi; Anna Kubo; Yasuo Ontachi; Tomoe Hayashi; Mika Omote; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Tomotaka Yoshida; Ken-Ichi Miyamoto; Shinji Nakao
Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Critical care medicine 2006;34(9):2421-5.
2006: Tomoe Hayashi; Eriko Morishita; Yasuo Ontachi; Masahide Yamazaki; Hidesaku Asakura; Takashi Yoshida; Shinji Nakao
Effects of sarpogrelate hydrochloride in a patient with chronic graft-versus-host disease: a case report.
American journal of hematology 2006;81(2):121-3.
2006: Minoru Hasegawa; Manabu Fujimoto; Ikuko Hayakawa; Takashi Matsushita; Chihiro Nishijima; Masahide Yamazaki; Kazuhiko Takehara; Shinichi Sato
Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.
Clinical and experimental rheumatology 2006;24(1):19-24.
2005: Masahide Yamazaki
[Catastrophic antiphospholipid syndrome: CAPS].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2005;28(6):357-64.
2005: Yasuo Ontachi; Hidesaku Asakura; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Tomoe Hayashi; Masahide Yamazaki; Eriko Morishita; Masanori Saito; Shinji Minami; Shinji Nakao
Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Circulation journal : official journal of the Japanese Circulation Society 2005;69(9):1150-3.
2005: Hidesaku Asakura; R Asamura; Yasuo Ontachi; Tomoe Hayashi; Masahide Yamazaki; Eriko Morishita; Ken-ichi Miyamoto; Shinji Nakao
Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats.
Journal of thrombosis and haemostasis : JTH 2005;3(5):1050-5.
2005: Hidesaku Asakura; Risa Asamura; Yasuo Ontachi; Tomoe Hayashi; Mika Omote; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Eriko Morishita; Tomotaka Yoshida; Ken-Ichi Miyamoto; Shinji Nakao
Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
Thrombosis and haemostasis 2005;93(4):724-8.
2004: Minoru Hasegawa; Shinichi Sato; Koichi Yanaba; Kazuhiro Komura; Masahide Yamazaki; Kazuhiko Takehara
Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
Annals of the rheumatic diseases 2004;63(11):1514-7.
2004: Hidesaku Asakura; Yoko Sano; Tomotaka Yoshida; Mika Omote; Yasuo Ontachi; Tomoe Mizutani; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
Intensive care medicine 2004;30(10):1950-5.
2004: Yukio Suga; Hidesaku Asakura; Tomotaka Yoshida; Mika Omote; Yasuo Ontachi; Tomoe Mizutani; Masahide Yamazaki; Eriko Morishita; Shinji Nakao; Ken-ichi Miyamoto
Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(7):593-8.
2004: Hidesaku Asakura; Yoko Sano; Mika Omote; Tomotaka Yoshida; Yasuo Ontachi; Tomoe Mizutani; Minori Kaneda; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
International journal of hematology 2004;79(4):394-9.
2004: Yasuo Ontachi; Hidesaku Asakura; Hisashi Funada; Akiyoshi Takami; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Tomoe Mizutani; Minori Kaneda; Takako Ito; Shinji Nakao
An idiopathic skin eruption resembling a butterfly rash in a septic patient with disseminated intravascular coagulation following bone marrow transplantation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(3):255-9.
2004: Hidesaku Asakura; Mariko Okudaira; Yasuo Ontachi; Tomoe Mizutani; Mika Omote; Tomotaka Yoshida; Minori Kaneda; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Antithrombotic role of nitric oxide in rats under physiological conditions.
Thrombosis and haemostasis 2004;91(1):71-5.
2003: Hidesaku Asakura; Yukio Suga; Tomotaka Yoshida; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Takako Ito; Eriko Morishita; Masahide Yamazaki; Ken-Ichi Miyamoto; Shinji Nakao
Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(3):221-8.
2002: Hidesaku Asakura; Mariko Okudaira; Tomotaka Yoshida; Yasuo Ontachi; Masahide Yamazaki; Eriko Morishita; Ken-ichi Miyamoto; Shinji Nakao
Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats.
Thrombosis and haemostasis 2002;88(4):663-7.
2002: Ontachi Yasuo; Hidesaku Asakura; Akiyoshi Takami; Tomoe Mizutani; Minori Kato; Takako Ito; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Shinichi Hayashi; Shinji Minami; Shinji Nakao
A case of cardiac B cell lymphoma complicated by hemophagocytic syndrome.
Haematologica 2002;87(8):ECR27.
2002: Hidesaku Asakura; T Ichino; Tomotaka Yoshida; Yukio Suga; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Takako Ito; Masahide Yamazaki; Keiji Aoshima; Eriko Morishita; Masanori Saito; Ken-ichi Miyamoto; Shinji Nakao
Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):233-9.
2002: Hidesaku Asakura; Yukio Suga; Keiji Aoshima; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats.
Critical care medicine 2002;30(1):161-4.
2001: Hidesaku Asakura; S Myou; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; M Saito; Eriko Morishita; Masahide Yamazaki; Shinji Nakao
Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(12):996-1000.
2001: Hidesaku Asakura; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Takako Ito; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Keiji Aoshima; Akiyoshi Takami; Tomotaka Yoshida; Yukio Suga; Ken-ichi Miyamoto; Shinji Nakao
Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
European journal of haematology 2001;67(3):170-5.
2001: Hidesaku Asakura; Keiji Aoshima; T Ichino; Yukio Suga; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Ken-ichi Miyamoto; Shinji Nakao
All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):301-6.
2001: Hidesaku Asakura; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Takako Ito; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Yukio Suga; Ken-ichi Miyamoto; Shinji Nakao
Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):275-81.
2001: Hidesaku Asakura; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Masanori Saito; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; Keiji Aoshima; Shinji Nakao
An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Critical care medicine 2001;29(6):1164-8.
2001: Eriko Morishita; K Yamaguchi; Hidesaku Asakura; Masanori Saito; Masahide Yamazaki; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Shinji Nakao
One missense mutation in the factor X gene causing factor X deficiency--factor X Kanazawa.
International journal of hematology 2001;73(3):390-2.
2001: Eriko Morishita; Hidesaku Asakura; M Saito; Masahide Yamazaki; Yasuo Ontachi; T Mizutani; M Kato; Shinji Nakao
[A point mutation at Arg169 (CGG-->TGG) in hereditary protein C deficiency].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2001;42(2):104-9.
2001: Hidesaku Asakura; Keiji Aoshima; Yukio Suga; Masahide Yamazaki; Eriko Morishita; Masanori Saito; Ken-ichi Miyamoto; Shinji Nakao
Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Thrombosis and haemostasis 2001;85(2):287-90.
2001: Hidesaku Asakura; Yasuo Ontachi; Tomoe Mizutani; Minori Kato; Masanori Saito; Eriko Morishita; Masahide Yamazaki; Yukio Suga; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(1):1-8.
1999: Masahide Yamazaki; T Mizutani; M Kato; Yasuo Ontachi; M Saito; Eriko Morishita; Hidesaku Asakura; Tamotsu Matsuda
[Aseptic meningitis induced by high-dose gamma-globulin in an adult woman with antiphospholipid syndrome and chronic idiopathic thrombocytopenic purpura].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1999;40(10):1110-5.
1999: Masahide Yamazaki; Keiji Aoshima; Tomoe Mizutani; Yasuo Ontachi; Masanori Saito; Eriko Morishita; Hidesaku Asakura; T Matsuda; D A Triplett
Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(6):321-30.
1998: Masahide Yamazaki; Hidesaku Asakura; Masanori Saito; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; Keiji Aoshima; T Matsuda; D A Triplett
Prothrombin fragment 1 + 2 measures treatment effect in patients with antiphospholipid syndrome.
Thrombosis research 1998;91(3):121-8.
1998: Eriko Morishita; T Hashimoto; Hidesaku Asakura; Masanori Saito; Masahide Yamazaki; Keiji Aoshima; Tomotaka Yoshida; H Kato; T Matsuda
Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.
Thrombosis and haemostasis 1998;79(5):919-23.
1998: Keiji Aoshima; Hidesaku Asakura; Masahide Yamazaki; Masanori Saito; I Kumabashiri; Eriko Morishita; Yasuo Ontachi; Tomoe Mizutani; T Ichino; T Matsuda
Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
Seminars in thrombosis and hemostasis 1998;24(3):227-31.
1996: Masanori Saito; Eriko Morishita; Hidesaku Asakura; H Jokaji; C Uotani; I Kumabashiri; Masahide Yamazaki; Keiji Aoshima; T Matsuda
[Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1996;37(9):794-8.
1996: Eriko Morishita; Shinji Nakao; Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Masahide Yamazaki; T Yoshida; K Takemoto; Keiji Aoshima; T Hashimoto; T Matsuda
Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(6):609-14.
1996: Eriko Morishita; Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Masahide Yamazaki; Keiji Aoshima; T Hashimoto; T Matsuda
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Atherosclerosis 1996;120(1-2):7-14.
1996: Masahide Yamazaki; Hidesaku Asakura; Keiji Aoshima; Masanori Saito; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; T Ikeda; T Matsuda
Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Seminars in thrombosis and hemostasis 1996;22(3):255-9.
1995: Akiyoshi Takami; Shinji Nakao; Naomi Sugimori; F Ishida; Masahide Yamazaki; Y Nakatsumi; Masanori Saito; S Otake; S Nakamura; T Matsuda
Management of disseminated intra-abdominal lymphangiomatosis with protein-losing enteropathy and intestinal bleeding.
Southern medical journal 1995;88(11):1156-8.
1995: Masanori Saito; Hidesaku Asakura; T Yoshida; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; Keiji Aoshima; T Matsuda
Levels of activated factor VII in patients with disseminated intravascular coagulation.
Blood 1995;85(12):3770-1.
1995: Masanori Saito; Hidesaku Asakura; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Yoshida; Keiji Aoshima; T Matsuda
Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis.
European journal of haematology 1995;54(3):176-9.
1995: Masahide Yamazaki; Hidesaku Asakura; Masanori Saito; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; Keiji Aoshima; T Sato; Y Tsugawa
Relationship between elevation in the plasma concentration of elastase-alpha 1 proteinase inhibitor complex (E-alpha 1 PI) and haemostatic parameters during haemodialysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(1):5-10.
1995: Masanori Saito; Hidesaku Asakura; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; Keiji Aoshima; T Matsuda
Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(1):60-4.
1995: T Matsuda; Eriko Morishita; H Jokaji; Masanori Saito; I Kumabashiri; H Akakura; C Uotani; Masahide Yamazaki
Plasminogen activator inhibitor in plasma and arteriosclerosis.
Annals of the New York Academy of Sciences 1995;748():394-8.
1994: Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; Keiji Aoshima; T Matsuda
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(5):829-32.
1994: Masahide Yamazaki; Y Kawamura; Takio Ohka; S Katada; K Morita; M Nakagawa; E Kubo; A Kawashima; H Shimizu; Kouichi Nobata
Cavernous lymphangioma of the spleen in a patient with Klippel-Trenaunay-Weber syndrome.
Internal medicine (Tokyo, Japan) 1994;33(9):574-7.
1994: Masahide Yamazaki; Hidesaku Asakura; Keiji Aoshima; Masanori Saito; H Jokaji; C Uotani; I Kumabashiri; Eriko Morishita; T Ikeda; T Matsuda
Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Thrombosis and haemostasis 1994;72(3):392-6.
1994: Masahide Yamazaki; Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Keiji Aoshima; T Ikeda; T Matsuda
Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome.
Thrombosis and haemostasis 1994;71(4):424-7.
1993: M Hasegawa; Junkoh Yamashita; T Yamashima; K Ikeda; Y Fujishima; Masahide Yamazaki
Spinal cord infarction associated with primary antiphospholipid syndrome in a young child. Case report.
Journal of neurosurgery 1993;79(3):446-50.
1993: Masahide Yamazaki; Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; S Nakamura; T Naito; H Ohta
Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993;4(3):491-5.
1993: Hidesaku Asakura; Y Shiratori; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation.
Acta haematologica 1993;89(1):22-5.
1992: Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
Role of endothelin in disseminated intravascular coagulation.
American journal of hematology 1992;41(2):71-5.
1992: Hidesaku Asakura; Senshu Hifumi; H Jokaji; Masanori Saito; I Kumabashiri; C Uotani; Eriko Morishita; Masahide Yamazaki; K Shibata; Keiichi Mizuhashi
Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1992;3(4):469-73.
1992: Eriko Morishita; Masanori Saito; Hidesaku Asakura; H Jokaji; C Uotani; I Kumabashiri; Masahide Yamazaki; T Matsuda
Increased levels of plasma thrombomodulin in chronic myelogenous leukemia.
American journal of hematology 1992;39(3):183-7.
1992: Masahide Yamazaki; Hidesaku Asakura; T Sato; Y Tsugawa; M Matsumura; Y Kawamura; Takio Ohka; T Matsuda
Changes in plasma levels of thrombomodulin during haemodialysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1992;3(1):113-7.
1991: Masahide Yamazaki; Hidesaku Asakura; Y Kawamura; Takio Ohka; M Endo; T Matsuda
Transient lupus anticoagulant induced by Epstein-Barr virus infection.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(6):771-4.
1991: Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
American journal of hematology 1991;38(4):281-7.
1991: Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(5):623-7.
1991: Eriko Morishita; Masanori Saito; Hidesaku Asakura; H Jokaji; C Uotani; I Kumabashiri; Masahide Yamazaki; H Hachiya; M Okamura; T Matsuda
Prothrombin Himi; an abnormal prothrombin characterized by a defective thrombin activity.
Thrombosis research 1991;62(6):697-706.
1991: Hidesaku Asakura; H Jokaji; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
American journal of hematology 1991;36(3):176-83.
1990: H Jokaji; Hidesaku Asakura; Masanori Saito; C Uotani; I Kumabashiri; Eriko Morishita; Masahide Yamazaki; T Matsuda
[Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1990;27(6):699-705.